173 related articles for article (PubMed ID: 30431136)
21. Signal Activation of Hepatitis B Virus-Related Hepatocarcinogenesis by Up-regulation of SUV39h1.
Takeuchi Y; Tsuge M; Tsushima K; Suehiro Y; Fujino H; Ono A; Yamauchi M; Makokha GN; Nakahara T; Murakami E; Abe-Chayama H; Kawaoka T; Miki D; Imamura M; Aikata H; Hayes CN; Tateno C; Chayama K
J Infect Dis; 2020 Nov; 222(12):2061-2070. PubMed ID: 32514521
[TBL] [Abstract][Full Text] [Related]
22. Hepatitis B virus X protein overcomes all-trans retinoic acid-induced cellular senescence by downregulating levels of p16 and p21 via DNA methylation.
Park SH; Jung JK; Lim JS; Tiwari I; Jang KL
J Gen Virol; 2011 Jun; 92(Pt 6):1309-1317. PubMed ID: 21325480
[TBL] [Abstract][Full Text] [Related]
23. Hepatitis B virus X induces cell proliferation in the hepatocarcinogenesis via up-regulation of cytoplasmic p21 expression.
Yano M; Ohkoshi S; Aoki YH; Takahashi H; Kurita S; Yamazaki K; Suzuki K; Yamagiwa S; Sanpei A; Fujimaki S; Wakai T; Kudo SE; Matsuda Y; Aoyagi Y
Liver Int; 2013 Sep; 33(8):1218-29. PubMed ID: 23590292
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis B virus X protein promotes DNA damage propagation through disruption of liver polyploidization and enhances hepatocellular carcinoma initiation.
Ahodantin J; Bou-Nader M; Cordier C; Mégret J; Soussan P; Desdouets C; Kremsdorf D
Oncogene; 2019 Apr; 38(14):2645-2657. PubMed ID: 30538294
[TBL] [Abstract][Full Text] [Related]
25. Linc00152 promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
Deng X; Zhao XF; Liang XQ; Chen R; Pan YF; Liang J
Biomed Pharmacother; 2017 Jun; 90():100-108. PubMed ID: 28343069
[TBL] [Abstract][Full Text] [Related]
26. Hepatitis B virus X protein promotes human hepatoma cell growth via upregulation of transcription factor AP2α and sphingosine kinase 1.
Lu ZP; Xiao ZL; Yang Z; Li J; Feng GX; Chen FQ; Li YH; Feng JY; Gao YE; Ye LH; Zhang XD
Acta Pharmacol Sin; 2015 Oct; 36(10):1228-36. PubMed ID: 26073327
[TBL] [Abstract][Full Text] [Related]
27. Fusion HBx from HBV integrant affects hepatocarcinogenesis through deregulation of ER stress response.
Muroyama R; Nakagawa R; Matsubara Y; Hirata Y; Omata M; Shirasawa H; Kato N
Virus Res; 2022 Jul; 315():198787. PubMed ID: 35430320
[TBL] [Abstract][Full Text] [Related]
28. HBx acts as an oncogene and promotes the invasion and metastasis of hepatocellular carcinoma both in vivo and vitro.
Yang S; Liu Y; Feng X; Wang X; Wu M; Gong L; Shu B; Lu Q; Dong J
Dig Liver Dis; 2021 Mar; 53(3):360-366. PubMed ID: 33153927
[TBL] [Abstract][Full Text] [Related]
29. miR-338-3p is down-regulated by hepatitis B virus X and inhibits cell proliferation by targeting the 3'-UTR region of CyclinD1.
Fu X; Tan D; Hou Z; Hu Z; Liu G
Int J Mol Sci; 2012; 13(7):8514-8539. PubMed ID: 22942717
[TBL] [Abstract][Full Text] [Related]
30. HBx-induced miR-21 suppresses cell apoptosis in hepatocellular carcinoma by targeting interleukin-12.
Yin D; Wang Y; Sai W; Zhang L; Miao Y; Cao L; Zhai X; Feng X; Yang L
Oncol Rep; 2016 Oct; 36(4):2305-12. PubMed ID: 27571873
[TBL] [Abstract][Full Text] [Related]
31. A novel mutant 10Ala/Arg together with mutant 144Ser/Arg of hepatitis B virus X protein involved in hepatitis B virus-related hepatocarcinogenesis in HepG2 cell lines.
Shi Y; Wang J; Wang Y; Wang A; Guo H; Wei F; Mehta SR; Espitia S; Smith DM; Liu L; Zhang Y; Chen D
Cancer Lett; 2016 Feb; 371(2):285-91. PubMed ID: 26706415
[TBL] [Abstract][Full Text] [Related]
32. Hepatitis B Virus HBx Activates Notch Signaling via Delta-Like 4/Notch1 in Hepatocellular Carcinoma.
Kongkavitoon P; Tangkijvanich P; Hirankarn N; Palaga T
PLoS One; 2016; 11(1):e0146696. PubMed ID: 26766040
[TBL] [Abstract][Full Text] [Related]
33. HBx induces hepatocellular carcinogenesis through ARRB1-mediated autophagy to drive the G
Lei Y; Xu X; Liu H; Chen L; Zhou H; Jiang J; Yang Y; Wu B
Autophagy; 2021 Dec; 17(12):4423-4441. PubMed ID: 33866937
[TBL] [Abstract][Full Text] [Related]
34. MiR-19a, miR-122 and miR-223 are differentially regulated by hepatitis B virus X protein and involve in cell proliferation in hepatoma cells.
Yu G; Chen X; Chen S; Ye W; Hou K; Liang M
J Transl Med; 2016 May; 14(1):122. PubMed ID: 27150195
[TBL] [Abstract][Full Text] [Related]
35. Epigenetic silencing of SFRP1 and SFRP5 by hepatitis B virus X protein enhances hepatoma cell tumorigenicity through Wnt signaling pathway.
Xie Q; Chen L; Shan X; Shan X; Tang J; Zhou F; Chen Q; Quan H; Nie D; Zhang W; Huang AL; Tang N
Int J Cancer; 2014 Aug; 135(3):635-46. PubMed ID: 24374650
[TBL] [Abstract][Full Text] [Related]
36. Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma.
Xia L; Huang W; Tian D; Zhu H; Zhang Y; Hu H; Fan D; Nie Y; Wu K
J Hepatol; 2012 Sep; 57(3):600-12. PubMed ID: 22613004
[TBL] [Abstract][Full Text] [Related]
37. The X protein of hepatitis B virus inhibits apoptosis in hepatoma cells through enhancing the methionine adenosyltransferase 2A gene expression and reducing S-adenosylmethionine production.
Liu Q; Chen J; Liu L; Zhang J; Wang D; Ma L; He Y; Liu Y; Liu Z; Wu J
J Biol Chem; 2011 May; 286(19):17168-80. PubMed ID: 21247894
[TBL] [Abstract][Full Text] [Related]
38. Hepatitis B virus X protein and hypoxia‑inducible factor-1α stimulate Notch gene expression in liver cancer cells.
Yang SL; Ren QG; Zhang T; Pan X; Wen L; Hu JL; Yu C; He QJ
Oncol Rep; 2017 Jan; 37(1):348-356. PubMed ID: 27840976
[TBL] [Abstract][Full Text] [Related]
39. Hepatitis B virus X protein shifts human hepatic transforming growth factor (TGF)-beta signaling from tumor suppression to oncogenesis in early chronic hepatitis B.
Murata M; Matsuzaki K; Yoshida K; Sekimoto G; Tahashi Y; Mori S; Uemura Y; Sakaida N; Fujisawa J; Seki T; Kobayashi K; Yokote K; Koike K; Okazaki K
Hepatology; 2009 Apr; 49(4):1203-17. PubMed ID: 19263472
[TBL] [Abstract][Full Text] [Related]
40. c-Jun N-terminal kinase inhibitor favors transforming growth factor-β to antagonize hepatitis B virus X protein-induced cell growth promotion in hepatocellular carcinoma.
Wu YH; Ai X; Liu FY; Liang HF; Zhang BX; Chen XP
Mol Med Rep; 2016 Feb; 13(2):1345-52. PubMed ID: 26648552
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
